Flora Growth (FLGC) Projected to Post Earnings on Monday

Flora Growth (NASDAQ:FLGC) is anticipated to release its Q2 2025 earnings data before the market opens on Monday, August 11th. Analysts expect Flora Growth to post earnings of ($0.06) per share and revenue of $11.77 million for the quarter.

Flora Growth (NASDAQ:FLGC) last released its quarterly earnings results on Friday, August 1st. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.05). Flora Growth had a negative net margin of 24.86% and a negative return on equity of 261.57%. The business had revenue of $14.80 million during the quarter, compared to the consensus estimate of $11.77 million. On average, analysts expect Flora Growth to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Flora Growth Stock Performance

Flora Growth stock opened at $18.65 on Friday. The stock has a 50-day simple moving average of $24.75 and a 200 day simple moving average of $25.92. The company has a quick ratio of 0.67, a current ratio of 0.96 and a debt-to-equity ratio of 0.50. Flora Growth has a 12-month low of $15.15 and a 12-month high of $82.29. The stock has a market capitalization of $10.81 million, a price-to-earnings ratio of -0.54 and a beta of 1.97.

Analyst Ratings Changes

Separately, Roth Capital set a $30.00 price target on Flora Growth and gave the company a “buy” rating in a report on Tuesday.

Institutional Trading of Flora Growth

A hedge fund recently raised its stake in Flora Growth stock. Geode Capital Management LLC boosted its position in shares of Flora Growth Corp. (NASDAQ:FLGC) by 1.8% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 168,572 shares of the company’s stock after purchasing an additional 3,015 shares during the quarter. Geode Capital Management LLC owned about 29.16% of Flora Growth worth $98,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 36.01% of the company’s stock.

About Flora Growth

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.